Skin Laboratory PCL (BKK:SKIN)
Thailand flag Thailand · Delayed Price · Currency is THB
1.130
-0.020 (-1.74%)
Last updated: Mar 9, 2026, 4:27 PM ICT

Skin Laboratory PCL Income Statement

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
176.73229.13271.8282.12197.55
Other Revenue
2.231.40.990.581.03
178.96230.53272.8282.7198.57
Revenue Growth (YoY)
-22.37%-15.49%-3.50%42.37%17.80%
Cost of Revenue
49.5357.563.2370.6565.56
Gross Profit
129.43173.03209.56212.05133.02
Selling, General & Admin
123.69159.5188.28196.8696.43
Operating Expenses
123.69159.5188.28196.8696.43
Operating Income
5.7413.5321.2815.1936.59
Interest Expense
-0.15-0.25-0.19-0.18-0.18
EBT Excluding Unusual Items
5.5913.2821.115.0136.41
Gain (Loss) on Sale of Investments
-0.25-0.07--
Pretax Income
5.5913.5321.0215.0136.41
Income Tax Expense
1.212.864.243.157.64
Net Income
4.3810.6716.7911.8628.77
Net Income to Common
4.3810.6716.7911.8628.77
Net Income Growth
-58.97%-36.44%41.59%-58.80%0.10%
Shares Outstanding (Basic)
11343222
Shares Outstanding (Diluted)
11343222
Shares Change (YoY)
162.19%2048.36%---
EPS (Basic)
0.040.258.395.9314.39
EPS (Diluted)
0.040.258.395.9314.39
EPS Growth
-84.35%-97.04%41.59%-58.80%-
Free Cash Flow
11.973.5726.254.6210.87
Free Cash Flow Per Share
0.110.0813.122.315.43
Dividend Per Share
-27.5807.5008.0006.830
Dividend Growth
-267.73%-6.25%17.13%1.19%
Gross Margin
72.32%75.06%76.82%75.01%66.98%
Operating Margin
3.21%5.87%7.80%5.37%18.42%
Profit Margin
2.45%4.63%6.15%4.19%14.49%
Free Cash Flow Margin
6.69%1.55%9.62%1.63%5.47%
EBITDA
6.214.4321.6215.6137.03
EBITDA Margin
3.47%6.26%7.93%5.52%18.65%
D&A For EBITDA
0.460.90.340.420.44
EBIT
5.7413.5321.2815.1936.59
EBIT Margin
3.21%5.87%7.80%5.37%18.42%
Effective Tax Rate
21.72%21.16%20.16%20.99%20.97%
Revenue as Reported
178.96230.53272.8282.7198.57
Advertising Expenses
89.63123.68150.16-48.6
Source: S&P Global Market Intelligence. Standard template. Financial Sources.